About Us

News & Events

We’re committed to providing the tools to help you stay at the forefront of industry advancements. Through our series of articles, webinars and other educational resources, you’ll gain invaluable insights to help you maximize lab performance and provide a higher level of care to your patients.

We’re committed to providing the tools to help you stay at the forefront of industry advancements. Through our series of articles, webinars and other educational resources, you’ll gain invaluable insights to help you maximize lab performance and provide a higher level of care to your patients.

featured-grid-icon

Recent Press Releases

featured-grid-img
Press Release

QuidelOrtho Announces $300 Million Share Repurchase Authorization | Ortho Clinical Diagnostics

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that its board of directors has authorized the repurchase of up to $300 million of shares of QuidelOrtho’s common stock over the next two years.

Read about recent news and events

Read about recent news and events

Search topics, categories and more...